Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | EPHA2 | P29317 | 3/20 | 0.31 |
| ▸ | KDR | P35968 | 3/20 | 0.31 |
| ▸ | EPHB4 | P54760 | 3/20 | 0.31 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.31 |
| ▸ | FLT1 | P17948 | 2/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15887264 | 1.00 | BCHE (0.35) | BCHEALDH1A1EPHA2KDREPHB4 | |
| SCHEMBL26383424 | 0.82 | BCHE (0.36) | BCHEALDH1A1EPHA2KDREPHB4 | |
| SCHEMBL24621365 | 0.82 | BCHE (0.36) | BCHEALDH1A1EPHA2KDREPHB4 | |
| SCHEMBL24621369 | 0.82 | BCHE (0.36) | BCHEALDH1A1EPHA2KDREPHB4 | |
| SCHEMBL17456251 | 0.80 | EPHA2 (0.35) | BCHEALDH1A1EPHA2KDREPHB4 | |
| SCHEMBL20105321 | 0.80 | EPHA2 (0.35) | BCHEALDH1A1EPHA2KDREPHB4 | |
| SCHEMBL1368298 | 0.80 | ALDH1A1 (0.42) | BCHEALDH1A1MAPT | |
| SCHEMBL17252148 | 0.80 | ALDH1A1 (0.42) | BCHEALDH1A1MAPT | |
| SCHEMBL21699136 | 0.80 | THRB (0.38) | — | |
| SCHEMBL22627598 | 0.80 | ALDH1A1 (0.42) | BCHEALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9321783-B2 | Method for preparing dialkyloxydianhyrohexitol by etherification of dianhydrohexitol using a light alcohol, in the presence of an acidic catalyst | ROQUETTE FRERES (FR) | 2016-04-26 | — | — | US | disclosed |
| US-20150203507-A1 | METHOD FOR PREPARING DIALKYLOXYDIANHYROHEXITOL BY ETHERIFICATION OF DIANHYDROHEXITOL USING A LIGHT ALCOHOL, IN THE PRESENCE OF AN ACIDIC CATALYST | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS (FR) | 2015-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150203507-A1 | METHOD FOR PREPARING DIALKYLOXYDIANHYROHEXITOL BY ETHERIFICATION OF DIANHYDROHEXITOL USING A LIGHT ALCOHOL, IN THE PRESENCE OF AN ACIDIC CATALYST | ADH1C, SI, SORD | BCHE 460/4885ALDH1A1 854/4885EPHA2 3883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.